IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Filed Feb 12, 2015 · 10-Q · 43 days after period end · 0001185185-15-000287
| Metric | Q3 2015 | Q3 2014 | Q3 2010 |
|---|---|---|---|
| Revenue | $2.54M | $17.53K | $484.11K |
| Net Income | -$590.11K | -$310.48K | -$1.75M |
| EPS Diluted | -$0.05 | -$0.04 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 12, 2015 · 43 d after period end
